Literature DB >> 28496648

Dabigatran, A Direct Thrombin Inhibitor, In Atrial Fibrillation: Is It Already Time For A Change In Oral Anticoagulation Therapy?

Osmar Antonio Centurión1.   

Abstract

Entities:  

Year:  2010        PMID： 28496648      PMCID： PMC4956206          DOI： 10.4022/jafib.234

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN： 1941-6911


× No keyword cloud information.
  23 in total

1.  Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.

Authors:  Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

Review 2.  Electrophysiologic characteristics of human atrial muscle in paroxysmal atrial fibrillation.

Authors:  K Hashiba; O A Centurion; A Shimizu
Journal:  Am Heart J       Date:  1996-04       Impact factor: 4.749

3.  Atrial fibrillation is associated with severe acute ischemic stroke.

Authors:  Douglas A Dulli; Heather Stanko; Ross L Levine
Journal:  Neuroepidemiology       Date:  2003 Mar-Apr       Impact factor: 3.282

Review 4.  Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Daniel E Singer; Gregory W Albers; James E Dalen; Alan S Go; Jonathan L Halperin; Warren J Manning
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

5.  The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Jack Ansell; Jack Hirsh; Leon Poller; Henry Bussey; Alan Jacobson; Elaine Hylek
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

6.  Stroke severity in atrial fibrillation. The Framingham Study.

Authors:  H J Lin; P A Wolf; M Kelly-Hayes; A S Beiser; C S Kase; E J Benjamin; R B D'Agostino
Journal:  Stroke       Date:  1996-10       Impact factor: 7.914

7.  Warfarin, aspirin, or both after myocardial infarction.

Authors:  Mette Hurlen; Michael Abdelnoor; Pål Smith; Jan Erikssen; Harald Arnesen
Journal:  N Engl J Med       Date:  2002-09-26       Impact factor: 91.245

Review 8.  Mechanisms for the genesis of paroxysmal atrial fibrillation in the Wolff Parkinson-White syndrome: intrinsic atrial muscle vulnerability vs. electrophysiological properties of the accessory pathway.

Authors:  Osmar Antonio Centurión; Akihiko Shimizu; Shojiro Isomoto; Atsushi Konoe
Journal:  Europace       Date:  2008-03       Impact factor: 5.214

9.  Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation.

Authors:  Elena Birman-Deych; Martha J Radford; David S Nilasena; Brian F Gage
Journal:  Stroke       Date:  2006-03-09       Impact factor: 7.914

10.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

Authors:  W M Feinberg; J L Blackshear; A Laupacis; R Kronmal; R G Hart
Journal:  Arch Intern Med       Date:  1995-03-13
View more
  1 in total

1.  Impact of VKORC1, CYP2C9, CYP1A2, UGT1A1, and GGCX polymorphisms on warfarin maintenance dose: Exploring a new algorithm in South Chinese patients accept mechanical heart valve replacement.

Authors:  Jin Li; Tao Chen; Fangfang Jie; Haiyan Xiang; Li Huang; Hongfa Jiang; Fei Lu; Shuqiang Zhu; Lidong Wu; Yanhua Tang
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.